Fulton Financial Co. (NASDAQ:FULT) Raises Dividend to $0.18 Per ShareUS authorities on Tuesday charged the man suspected of gunning down a health insurance CEO in New York earlier this month with murder, including a charge of second-degree murder "as an act of terrorism." Mangione, 26, is accused of shooting UnitedHealthcare chief executive Brian Thompson on a Manhattan street on December 4, triggering a nationwide manhunt that ended last week when he was spotted at a Pennsylvania McDonald's. The former data engineer remains jailed in that state as he fights efforts to extradite him to New York to face charges there over the killing, which brought into focus widespread public anger against the US health care system. Mangione "is charged with one count of murder in the first degree and two counts of murder in the second degree, including one count of murder in the second degree as an act of terrorism," said Manhattan district attorney Alvin Bragg. Bragg said the terrorism charge was included because the shooting met the prerequisites for such a determination under New York law. "In its most basic terms, this was a killing that was intended to evoke terror and we've seen that reaction," he said. "This was not an ordinary killing." The maximum penalty for the murder charges Mangione faces is life in prison without parole, Bragg said. The suspect was also charged with several crimes related to his possession of a weapon, which authorities said was a 3D-printed "ghost gun." "We allege he... took out a nine-millimeter 3D-printed ghost gun equipped with a 3D-printed suppressor and shot (Thompson) once in the back and once in the leg," said Bragg. "These weapons are increasingly proliferating throughout New York City and the entire country. Evolving technology will only make this problem worse," he said. "Last year, over 80 ghost guns and ghost gun parts were recovered in Manhattan alone." In the wake of Thompson's killing, many social media users have lionized Mangione, with some even calling for further killings of other CEOs. Jessica Tisch, the New York City police commissioner, criticized members of the public who had praised the murder. "In the nearly two weeks since Mr Thompson's killing, we have seen a shocking and appalling celebration of cold-blooded murder," said Tisch. Mangione is due in Pennsylvania court on Thursday for a hearing on his extradition to New York. Police say a "life-changing, life-altering" back injury may have motivated Mangione, although they added that there was "no indication" that he was ever a client of UnitedHealthcare. When he was arrested, Mangione had a three-page handwritten text criticizing the US health care system. Police have said that Mangione's fingerprints matched those found near the crime scene, and that shell casings match the gun found on him when he was arrested. Bragg said that the suspect traveled to New York on November 24 with the intention of murdering Thompson. On December 4, he is alleged to have waited "for nearly an hour" outside the hotel where Thompson was shot early that morning. "This was a frightening, well planned, targeted murder that was intended to cause shock and attention and intimidation," said district attorney Bragg. bur-aha/md
Durban [South Africa], : Ace seamer Shaheen Afridi etched his name in the history book by becoming Pakistan's first bowler to take 100 wickets in each format of international cricket. In the first innings of the opening T20I against South Africa in Durban here on Tuesday night, Shaheen struck once in the powerplay, then in the middle phase and once towards the end to complete a three-wicket haul and arrive at the rare feat. With a three-wicket haul, Shaheen completed 100 T20I wickets and became the first Pakistan bowler to have 100 wickets in each format. Apart from T20Is, the 24-year-old left-arm seamer boasts 112 scalps in ODIs and 116 in Test cricket. With his record-shattering spell, he also the became third Pakistani bowler to achieve 100 T20I wickets, behind Haris Rauf and Shadab Khan. Shaheen hit the three-digit figure milestone in his 74th T20I game for Pakistan. He became the second-fastest to take 100 T20I wickets for Pakistan after scorching pacer Haris Rauf, who achieved the feat in 71 T20I matches. Overall, Shaheen became the youngest to achieve the feat and joined the ranks of New Zealand's Tim Southee, Bangladesh's Shakib Al Hasan, and Sri Lanka's Lasith Malinga. Coming to the match, Shaheen cleaned up Rassie van der Dussen for a golden duck with a pinpoint yorker. He came back to send in-form David Miller before he could bring up a well-deserved century. In the last, he trapped Nqabayomzi Peter in front of the stumps to claim his 100th T20I wicket and enter the exclusive club. Shaheen ended the first T20I with figures of 3/22 in his four-over spell. Despite Shaheen's heroics, Pakistan fell to a narrow 11-run defeat. While chasing a challenging total of 184, skipper Mohammad Rizwan found no support from the other end. His 74 drove Pakistan's score but it wasn't enough to take the visitors past the finishing line. This article was generated from an automated news agency feed without modifications to text.After absorbing their worst defeat of the year , the San Jose Sharks will be looking for a response Saturday against the Florida Panthers. The Sharks reverted to some bad habits during their 8-1 loss to the Tampa Bay Lightning on Thursday, as they strayed from their identity and were generally outworked from start to finish. The seven-goal loss was the Sharks’ most lopsided of the season, unceremoniously ending a three-game winning streak. While the Sharks have been playing better hockey l ately, the loss in Tampa offered a blunt reminder that they can still get embarrassed when their details and competitive level are not where they need to be, particularly against playoff-caliber teams. “Break out pucks, defend hard, box out, you name it,” Sharks coach Ryan Warsofsky told reporters when asked about the defense’s shortcomings. “What a defenseman’s responsibilities are, we could have done a lot better.” The forward group wasn’t let off the hook, either. “Didn’t pay a price,” Warsofsky said. “You watch (the Lightning), they’re blocking shots. (Mikey) Eyssimont), (Luke) Glendining (when it’s) 8-1. And that’s the price to pay to win games in this league and that’s what we’ve got to learn.” The Sharks have done a fairly good job this season of responding after blowout defeats. After an 8-3 road loss to the Winnipeg Jets on Oct. 18, they returned home and played a much more competitive game two days later against the Colorado Avalanche in a 4-1 loss. Two days after getting blown out 7-3 by the Vegas Golden Knights on Oct. 26, the Sharks erased a three-goal deficit in the final five minutes of the third period against the Utah Hockey Club and won 5-4 in overtime. Now the Sharks face the reigning Stanley Cup champion Panthers, who, before Friday, were the third-highest scoring team in the NHL at 3.78 goals per game. Florida entered Friday tied for first place in the Atlantic Division with the Toronto Maple Leafs. “I’m not deflated. It’s an 82-game season,” Sharks defenseman Mario Ferraro said after Thursday’s loss. “We’ve got another game in a couple of days and another opportunity to play a really good hockey team and surprise them. So it’s not deflating, but it’s definitely not something that’s acceptable, so we’ve got to be better.” The Sharks have lost 10 straight games to the Panthers, with their last victory in South Florida coming on Dec.1, 2017. The Sharks might have to face the Panthers without rookie forward Will Smith, who did not practice Friday. Warsofsky told San Jose Hockey Now that Smith is day-to-day with an upper-body injury, although it remained unclear when the 19-year-old was injured. Against the Lightning, Smith played late into the third period and finished with 15:50 in ice time. Smith has 11 points in 23 games this season and has recently been playing on a line with Mikael Granlund and Klim Kostin. Regardless of who plays against the Panthers, the Sharks still need to prove that they can consistently produce a strong performance against quality opponents. “We’ll obviously take a look at everything and talk within the group and figure it out,” Sharks winger Luke Kunin said, “so it doesn’t happen again.” GOODROW RETURNS: Forward Barclay Goodrow, who has been on injured reserve since Nov. 28 with an upper-body ailment, skated Friday, per San Jose Hockey Now. Goodrow was injured by a high hit from Ridly Greig in the Sharks’ Nov. 27 game against the Ottawa Senators. He is questionable to play against the Panthers. TEDDY BEAR TOSS: The San Jose Barracuda are hosting its annual Teddy Bear Toss at Tech CU Arena on Saturday when it plays the Coachella Valley Firebirds at 6 p.m. Fans are urged to bring stuffed animals to the game and throw them on the ice after the Barracuda scores its first goal. The Barracuda will then distribute some of the stuffed animals to children at local Kaiser Permanente hospitals, as well as other kids who might not get a gift during this time of year. The AHL franchise is also joining forces with San Jose-based Working Partnerships USA, which, per the team, helps to tackle “the root causes of inequality and poverty by leading collaborative campaigns for quality jobs, healthy communities, equitable growth, and a vibrant democracy.” For Saturday’s game, the Barracuda will also wear specialty jerseys that will be auctioned off after the game, with part of the proceeds going to Working Partnerships. The team is also giving away Barracuda stockings to the first 1,500 fans in the building.
Singer Tabitha Nauser on her first year of motherhood: ‘Becoming a mum changed me for the better’Analysis: After Juan Soto's megadeal, could MLB see a $1 billion contract? Probably not soon
Trump introduces a line of guitars and announces that he will sell them for $10,000
Civilization 7 - Official Harriet Tubman Trailer The Freedom Fighter. Meet Harriet Tubman and learn about this leader's attributes in this Civilization 7 trailer for the upcoming turn-based strategy game. Sid Meier's Civilization 7 will be available on PS5, PS4, Xbox Series X|S, Xbox One, Nintendo Switch, and PC via Steam (which also supports Mac and Linux) and the Epic Games Store on February 11, 2025. Cross-play multiplayer is fully supported.In Civilization 7, your strategic decisions shape the unique cultural lineage of your evolving empire. Rule as one of many legendary leaders from throughout history and steer the course of your story by choosing a new civilization to represent your empire in each Age of human advancement.Construct cities and architectural wonders to expand your territory, improve your civilization with technological breakthroughs, and conquer or cooperate with rival civilizations as you explore the far reaches of the unknown world. Pursue prosperity in an immersive solo experience or play with others in online multiplayer.WALTHAM, Mass.--(BUSINESS WIRE)--Dec 6, 2024-- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO), to pursue other career opportunities, after nearly four years of dedicated service with the Company. Mr. Kelly has served as Vicarious Surgical’s CFO since January 2021. He will assist the Company to ensure minimal disruption and a successful transition of responsibilities prior to his departure, which is slated for January 2, 2025. “On behalf of the Company and Board, I want to extend my sincerest gratitude to Bill for his significant contribution over the last few years,” said Adam Sachs, Co-Founder and Chief Executive Officer. “Bill has been an incredible asset to Vicarious Surgical, and we wish him all the best in his future endeavors.” Mr. Kelly added “My tenure at Vicarious Surgical has been a period of significant progress and accomplishment, both for the Company and for me personally. I am deeply grateful for the opportunities I have been afforded and the collaborative spirit of the entire team. I depart with immense pride in our collective achievements and unwavering confidence in the Company's continued success under its strong leadership.” The Company has initiated a CFO succession process and will provide updates as appropriate. About Vicarious Surgical Founded in 2014, Vicarious Surgical is a next generation robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com . Forward-Looking Statements This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The company’s actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. All statements other than statements of historical facts contained herein, are forward-looking statements that reflect the current beliefs and expectations of management. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside Vicarious Surgical’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the ability to maintain the listing of Vicarious Surgical’s Class A common stock on the New York Stock Exchange; the approval, commercialization and adoption of Vicarious Surgical’s initial product candidates and the success of its single-port surgical robot, called the Vicarious Surgical System, and any of its future product candidates and service offerings; changes in applicable laws or regulations; the ability of Vicarious Surgical to raise financing in the future; the success, cost and timing of Vicarious Surgical’s product and service development activities; the potential attributes and benefits of Vicarious Surgical’s product candidates and services; Vicarious Surgical’s ability to obtain and maintain regulatory approval for the Vicarious Surgical System, and any related restrictions and limitations of any approved product; the size and duration of human clinical trials for the Vicarious Surgical System; Vicarious Surgical’s ability to identify, in-license or acquire additional technology; Vicarious Surgical’s ability to maintain its existing license, manufacture, supply and distribution agreements; Vicarious Surgical’s ability to compete with other companies currently marketing or engaged in the development of products and services that Vicarious Surgical is currently marketing or developing; the size and growth potential of the markets for Vicarious Surgical’s product candidates and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of Vicarious Surgical’s product candidates and services and reimbursement for medical procedures conducted using its product candidates and services; the company’s estimates regarding expenses, revenue, capital requirements and needs for additional financing; Vicarious Surgical’s financial performance; economic downturns, political and market conditions and their potential to adversely affect Vicarious Surgical’s business, financial condition and results of operations; Vicarious Surgical’s intellectual property rights and its ability to protect or enforce those rights, and the impact on its business, results and financial condition if it is unsuccessful in doing so; and other risks and uncertainties indicated from time to time in Vicarious Surgical’s filings with the SEC. Vicarious Surgical cautions that the foregoing list of factors is not exclusive. The company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vicarious Surgical does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. View source version on businesswire.com : https://www.businesswire.com/news/home/20241206242926/en/ CONTACT: Investors Kaitlyn Brosco Vicarious Surgical Kbrosco@vicarioussurgical.com Media Inquiries media@vicarioussurgical.com KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: MEDICAL SUPPLIES TECHNOLOGY OTHER HEALTH HEALTH ROBOTICS HEALTH TECHNOLOGY OTHER TECHNOLOGY MEDICAL DEVICES HOSPITALS SURGERY HARDWARE SOURCE: Vicarious Surgical Inc. Copyright Business Wire 2024. PUB: 12/06/2024 04:05 PM/DISC: 12/06/2024 04:05 PM http://www.businesswire.com/news/home/20241206242926/en
Wall Street's 3 Favorite 'Magnificent 7' Stocks to Own Now